Drug Type Biological products |
Synonyms |
Target- |
Mechanism- |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | US | 17 Jun 2024 | |
Amyotrophic Lateral Sclerosis | Preclinical | US | 17 Jun 2024 | |
Parkinson Disease | Preclinical | US | 17 Jun 2024 |